News on Affinity Technology Incorporated from BioPortfolio.com http://www.BioPortfolio.com Consolidated Affinity Technology Incorporated news from BioPortfolio.com Wed, 10 Feb 2010 04:36:37 GMT en ADVENTRX Appoints Icahn Representative to Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025541&HITNO=0&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025541&THISHREF=http://c.moreover.com/click/here.pl%3fz2529895556%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025541&HITNO=0&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025541&THISHREF=http://c.moreover.com/click/here.pl%3fz2529895556%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Reportlinker Adds Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012527&HITNO=1&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012527&THISHREF=http://c.moreover.com/click/here.pl%3fz2523455059%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012527&HITNO=1&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012527&THISHREF=http://c.moreover.com/click/here.pl%3fz2523455059%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Safe Place Viagra Onlinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011375&HITNO=2&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011375&THISHREF=http://c.moreover.com/click/here.pl%3fz2522896366%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011375&HITNO=2&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011375&THISHREF=http://c.moreover.com/click/here.pl%3fz2522896366%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBreeze, James Madison University: Phase Forward to Participate in Upcoming Investor Conferenceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005839&HITNO=3&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005839&THISHREF=http://c.moreover.com/click/here.pl%3fz2520501493%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005839&HITNO=3&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005839&THISHREF=http://c.moreover.com/click/here.pl%3fz2520501493%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Phase Forward to Participate in Upcoming Investor Conferenceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008651&HITNO=4&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008651&THISHREF=http://c.moreover.com/click/here.pl%3fz2521616645%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008651&HITNO=4&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008651&THISHREF=http://c.moreover.com/click/here.pl%3fz2521616645%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: ADVENTRX Appoints Icahn Representative to Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006056&HITNO=5&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006056&THISHREF=http://c.moreover.com/click/here.pl%3fz2520570736%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006056&HITNO=5&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006056&THISHREF=http://c.moreover.com/click/here.pl%3fz2520570736%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Phase Forward to Participate in Upcoming Investor Conferenceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005583&HITNO=6&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005583&THISHREF=http://c.moreover.com/click/here.pl%3fz2520396219%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005583&HITNO=6&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005583&THISHREF=http://c.moreover.com/click/here.pl%3fz2520396219%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: Phase Forward to Participate in Upcoming Investor Conferenceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005579&HITNO=7&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005579&THISHREF=http://c.moreover.com/click/here.pl%3fz2520394952%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005579&HITNO=7&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005579&THISHREF=http://c.moreover.com/click/here.pl%3fz2520394952%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: Phase Forward to Participate in Upcoming Investor Conferenceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005349&HITNO=8&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005349&THISHREF=http://c.moreover.com/click/here.pl%3fz2520333425%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005349&HITNO=8&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005349&THISHREF=http://c.moreover.com/click/here.pl%3fz2520333425%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Vertex Pharmaceuticals Incorporated-Deals & Alliances Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996281&HITNO=9&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996281&THISHREF=http://c.moreover.com/click/here.pl%3fz2516240931%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996281&HITNO=9&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996281&THISHREF=http://c.moreover.com/click/here.pl%3fz2516240931%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Houston Technology Center Client Company Salient Pharmaceuticals Incorporated Receives $2 Million Commercializhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3986559&HITNO=10&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3986559&THISHREF=http://c.moreover.com/click/here.pl%3fz2509245644%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3986559&HITNO=10&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3986559&THISHREF=http://c.moreover.com/click/here.pl%3fz2509245644%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Research and Markets: Therapeutic Monoclonal Antibodies: From Bench to Clinichttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983104&HITNO=11&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983104&THISHREF=http://c.moreover.com/click/here.pl%3fz2507692507%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983104&HITNO=11&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983104&THISHREF=http://c.moreover.com/click/here.pl%3fz2507692507%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Houston Technology Center Client Company Salient Pharmaceuticals Incorporated Receives $2 Million Commercializhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983788&HITNO=12&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983788&THISHREF=http://c.moreover.com/click/here.pl%3fz2507887663%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983788&HITNO=12&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983788&THISHREF=http://c.moreover.com/click/here.pl%3fz2507887663%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: Houston Technology Center Client Company Salient Pharmaceuticals Incorporated Receives $2 Million Commercialization Award From The Texas Emerging Technology Fundhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983604&HITNO=13&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983604&THISHREF=http://c.moreover.com/click/here.pl%3fz2507825882%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3983604&HITNO=13&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3983604&THISHREF=http://c.moreover.com/click/here.pl%3fz2507825882%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYour Story: Houston Technology Center Client Company Salient Pharmaceuticals Incorporated Receives $2 Million Commercialization Award From The Texas Emerging Technology Fundhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984583&HITNO=14&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984583&THISHREF=http://c.moreover.com/click/here.pl%3fz2508224659%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984583&HITNO=14&MSIZE=76&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Affinity%20Technology%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984583&THISHREF=http://c.moreover.com/click/here.pl%3fz2508224659%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKansas City Business Journal: